blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3281641

EP3281641 - ADJUVANT FOR CANCER VACCINES [Right-click to bookmark this link]
Former [2018/07]MEDICINE
[2020/26]
StatusNo opposition filed within time limit
Status updated on  22.10.2021
Database last updated on 25.09.2024
FormerThe patent has been granted
Status updated on  13.11.2020
FormerGrant of patent is intended
Status updated on  29.06.2020
FormerExamination is in progress
Status updated on  07.06.2019
FormerRequest for examination was made
Status updated on  12.01.2018
FormerThe international publication has been made
Status updated on  11.02.2017
Most recent event   Tooltip06.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 09.10.2024 [2024/41]
Applicant(s)For all designated states
Cytlimic Inc.
15-19, Kamiosaki 2-chome
Shinagawa-ku
Tokyo 1410021 / JP
[2018/07]
Inventor(s)01 / MIYAKAWA, Tomoya
c/o NEC Corporation
7-1 Shiba 5-chome
Minato-ku
Tokyo 108-8001 / JP
02 / DOI, Shun
c/o NEC Corporation
7-1 Shiba 5-chome
Minato-ku
Tokyo 108-8001 / JP
03 / TAMADA, Koji
c/o Yamaguchi University
Graduate School of Medicine
1-1-1 Minami-Kogushi
Ube-shi Yamaguchi 755-8505 / JP
 [2018/07]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2018/07]
Application number, filing date16776655.907.04.2016
[2018/07]
WO2016JP61463
Priority number, dateJP2015007868407.04.2015         Original published format: JP 2015078684
JP2015019806605.10.2015         Original published format: JP 2015198066
JP2016003204623.02.2016         Original published format: JP 2016032046
[2018/07]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016163489
Date:13.10.2016
Language:JA
[2016/41]
Type: A1 Application with search report 
No.:EP3281641
Date:14.02.2018
Language:EN
[2018/07]
Type: B1 Patent specification 
No.:EP3281641
Date:16.12.2020
Language:EN
[2020/51]
Search report(s)International search report - published on:JP13.10.2016
(Supplementary) European search report - dispatched on:EP16.11.2018
ClassificationIPC:A61K45/00, A61K38/00, A61K39/00, A61K39/39, A61P35/00, A61P43/00, A61P37/02
[2018/51]
CPC:
A61K38/177 (EP,RU,US); A61K31/7088 (RU); A61K2239/31 (EP,RU,US);
A61K2239/38 (EP,RU,US); A61K2239/57 (EP,RU,US); A61K38/00 (US);
A61K38/1709 (US); A61K38/18 (US); A61K39/00 (EP,RU,US);
A61K39/0011 (EP,RU,US); A61K39/39 (EP,US); A61K39/395 (RU);
A61K39/4611 (EP,RU,US); A61K39/464492 (EP,RU,US); A61K45/00 (EP,US);
A61K45/05 (US); A61K45/06 (EP); A61P35/00 (EP,RU,US);
A61P37/02 (EP,US); C07K14/475 (US); C07K19/00 (US);
C12N15/117 (US); A61K2039/555 (US); A61K2039/55511 (US);
A61K2039/57 (US); A61K2039/585 (US); C07K2319/30 (US) (-)
Former IPC [2018/07]A61K45/00, A61K38/00, A61K39/00, A61K39/39, A61P35/00, A61P43/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/07]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:ADJUVANT FÜR KREBSIMPFSTOFFE[2020/26]
English:ADJUVANT FOR CANCER VACCINES[2020/26]
French:ADJUVANT POUR LES VACCINS CONTRE LE CANCER[2020/26]
Former [2018/07]MEDIZIN
Former [2018/07]MEDICINE
Former [2018/07]MÉDICAMENT
Entry into regional phase24.10.2017Translation filed 
24.10.2017National basic fee paid 
24.10.2017Search fee paid 
24.10.2017Designation fee(s) paid 
24.10.2017Examination fee paid 
Examination procedure24.10.2017Examination requested  [2018/07]
24.10.2017Date on which the examining division has become responsible
08.05.2019Amendment by applicant (claims and/or description)
12.06.2019Despatch of a communication from the examining division (Time limit: M04)
25.09.2019Reply to a communication from the examining division
20.12.2019Despatch of a communication from the examining division (Time limit: M04)
20.04.2020Reply to a communication from the examining division
30.06.2020Communication of intention to grant the patent
05.11.2020Fee for grant paid
05.11.2020Fee for publishing/printing paid
05.11.2020Receipt of the translation of the claim(s)
Divisional application(s)EP20204940.9  / EP3797794
Opposition(s)17.09.2021No opposition filed within time limit [2021/47]
Fees paidRenewal fee
20.04.2018Renewal fee patent year 03
15.04.2019Renewal fee patent year 04
31.03.2020Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU07.04.2016
AL16.12.2020
AT16.12.2020
CY16.12.2020
CZ16.12.2020
EE16.12.2020
FI16.12.2020
HR16.12.2020
LT16.12.2020
LV16.12.2020
MC16.12.2020
MK16.12.2020
MT16.12.2020
NL16.12.2020
PL16.12.2020
RO16.12.2020
RS16.12.2020
SE16.12.2020
SI16.12.2020
SK16.12.2020
SM16.12.2020
BG16.03.2021
NO16.03.2021
GR17.03.2021
IE07.04.2021
LU07.04.2021
IS16.04.2021
PT16.04.2021
[2024/41]
Former [2024/22]HU07.04.2016
AL16.12.2020
AT16.12.2020
CY16.12.2020
CZ16.12.2020
EE16.12.2020
FI16.12.2020
HR16.12.2020
LT16.12.2020
LV16.12.2020
MC16.12.2020
MK16.12.2020
NL16.12.2020
PL16.12.2020
RO16.12.2020
RS16.12.2020
SE16.12.2020
SI16.12.2020
SK16.12.2020
SM16.12.2020
BG16.03.2021
NO16.03.2021
GR17.03.2021
IE07.04.2021
LU07.04.2021
IS16.04.2021
PT16.04.2021
Former [2023/30]HU07.04.2016
AL16.12.2020
AT16.12.2020
CY16.12.2020
CZ16.12.2020
EE16.12.2020
FI16.12.2020
HR16.12.2020
LT16.12.2020
LV16.12.2020
MC16.12.2020
NL16.12.2020
PL16.12.2020
RO16.12.2020
RS16.12.2020
SE16.12.2020
SI16.12.2020
SK16.12.2020
SM16.12.2020
BG16.03.2021
NO16.03.2021
GR17.03.2021
IE07.04.2021
LU07.04.2021
IS16.04.2021
PT16.04.2021
Former [2023/29]HU07.04.2016
AL16.12.2020
AT16.12.2020
CZ16.12.2020
EE16.12.2020
FI16.12.2020
HR16.12.2020
LT16.12.2020
LV16.12.2020
MC16.12.2020
NL16.12.2020
PL16.12.2020
RO16.12.2020
RS16.12.2020
SE16.12.2020
SI16.12.2020
SK16.12.2020
SM16.12.2020
BG16.03.2021
NO16.03.2021
GR17.03.2021
IE07.04.2021
LU07.04.2021
IS16.04.2021
PT16.04.2021
Former [2022/23]AL16.12.2020
AT16.12.2020
CZ16.12.2020
EE16.12.2020
FI16.12.2020
HR16.12.2020
LT16.12.2020
LV16.12.2020
MC16.12.2020
NL16.12.2020
PL16.12.2020
RO16.12.2020
RS16.12.2020
SE16.12.2020
SI16.12.2020
SK16.12.2020
SM16.12.2020
BG16.03.2021
NO16.03.2021
GR17.03.2021
IE07.04.2021
LU07.04.2021
IS16.04.2021
PT16.04.2021
Former [2022/21]AL16.12.2020
AT16.12.2020
CZ16.12.2020
EE16.12.2020
FI16.12.2020
HR16.12.2020
LT16.12.2020
LV16.12.2020
MC16.12.2020
NL16.12.2020
PL16.12.2020
RO16.12.2020
RS16.12.2020
SE16.12.2020
SI16.12.2020
SK16.12.2020
SM16.12.2020
BG16.03.2021
NO16.03.2021
GR17.03.2021
IE07.04.2021
LU07.04.2021
PT16.04.2021
Former [2022/13]AL16.12.2020
AT16.12.2020
CZ16.12.2020
EE16.12.2020
FI16.12.2020
HR16.12.2020
LT16.12.2020
LV16.12.2020
MC16.12.2020
NL16.12.2020
PL16.12.2020
RO16.12.2020
RS16.12.2020
SE16.12.2020
SI16.12.2020
SK16.12.2020
SM16.12.2020
BG16.03.2021
NO16.03.2021
GR17.03.2021
LU07.04.2021
PT16.04.2021
Former [2022/10]AL16.12.2020
AT16.12.2020
CZ16.12.2020
EE16.12.2020
FI16.12.2020
HR16.12.2020
LT16.12.2020
LV16.12.2020
MC16.12.2020
NL16.12.2020
PL16.12.2020
RO16.12.2020
RS16.12.2020
SE16.12.2020
SK16.12.2020
SM16.12.2020
BG16.03.2021
NO16.03.2021
GR17.03.2021
LU07.04.2021
PT16.04.2021
Former [2022/04]AL16.12.2020
AT16.12.2020
CZ16.12.2020
EE16.12.2020
FI16.12.2020
HR16.12.2020
LT16.12.2020
LV16.12.2020
MC16.12.2020
NL16.12.2020
PL16.12.2020
RO16.12.2020
RS16.12.2020
SE16.12.2020
SK16.12.2020
SM16.12.2020
BG16.03.2021
NO16.03.2021
GR17.03.2021
LU07.04.2021
IS16.04.2021
PT16.04.2021
Former [2021/50]AL16.12.2020
AT16.12.2020
CZ16.12.2020
EE16.12.2020
FI16.12.2020
HR16.12.2020
LT16.12.2020
LV16.12.2020
MC16.12.2020
NL16.12.2020
PL16.12.2020
RO16.12.2020
RS16.12.2020
SE16.12.2020
SK16.12.2020
SM16.12.2020
BG16.03.2021
NO16.03.2021
GR17.03.2021
IS16.04.2021
PT16.04.2021
Former [2021/45]AL16.12.2020
AT16.12.2020
CZ16.12.2020
EE16.12.2020
FI16.12.2020
HR16.12.2020
LT16.12.2020
LV16.12.2020
NL16.12.2020
PL16.12.2020
RO16.12.2020
RS16.12.2020
SE16.12.2020
SK16.12.2020
SM16.12.2020
BG16.03.2021
NO16.03.2021
GR17.03.2021
IS16.04.2021
PT16.04.2021
Former [2021/42]AT16.12.2020
CZ16.12.2020
EE16.12.2020
FI16.12.2020
HR16.12.2020
LT16.12.2020
LV16.12.2020
NL16.12.2020
PL16.12.2020
RO16.12.2020
RS16.12.2020
SE16.12.2020
SK16.12.2020
SM16.12.2020
BG16.03.2021
NO16.03.2021
GR17.03.2021
IS16.04.2021
PT16.04.2021
Former [2021/39]AT16.12.2020
CZ16.12.2020
EE16.12.2020
FI16.12.2020
HR16.12.2020
LT16.12.2020
LV16.12.2020
NL16.12.2020
PL16.12.2020
RO16.12.2020
RS16.12.2020
SE16.12.2020
SK16.12.2020
SM16.12.2020
BG16.03.2021
NO16.03.2021
GR17.03.2021
PT16.04.2021
Former [2021/37]AT16.12.2020
CZ16.12.2020
EE16.12.2020
FI16.12.2020
HR16.12.2020
LT16.12.2020
LV16.12.2020
NL16.12.2020
RO16.12.2020
RS16.12.2020
SE16.12.2020
SK16.12.2020
SM16.12.2020
BG16.03.2021
NO16.03.2021
GR17.03.2021
PT16.04.2021
Former [2021/36]CZ16.12.2020
EE16.12.2020
FI16.12.2020
HR16.12.2020
LT16.12.2020
LV16.12.2020
NL16.12.2020
RO16.12.2020
RS16.12.2020
SE16.12.2020
SK16.12.2020
SM16.12.2020
BG16.03.2021
NO16.03.2021
GR17.03.2021
PT16.04.2021
Former [2021/35]CZ16.12.2020
FI16.12.2020
HR16.12.2020
LT16.12.2020
LV16.12.2020
NL16.12.2020
RO16.12.2020
RS16.12.2020
SE16.12.2020
SK16.12.2020
SM16.12.2020
BG16.03.2021
NO16.03.2021
GR17.03.2021
PT16.04.2021
Former [2021/34]CZ16.12.2020
FI16.12.2020
HR16.12.2020
LT16.12.2020
LV16.12.2020
NL16.12.2020
RS16.12.2020
SE16.12.2020
SM16.12.2020
BG16.03.2021
NO16.03.2021
GR17.03.2021
PT16.04.2021
Former [2021/33]FI16.12.2020
HR16.12.2020
LT16.12.2020
LV16.12.2020
NL16.12.2020
RS16.12.2020
SE16.12.2020
SM16.12.2020
BG16.03.2021
NO16.03.2021
GR17.03.2021
PT16.04.2021
Former [2021/32]FI16.12.2020
HR16.12.2020
LV16.12.2020
NL16.12.2020
RS16.12.2020
SE16.12.2020
SM16.12.2020
BG16.03.2021
NO16.03.2021
GR17.03.2021
Former [2021/30]FI16.12.2020
HR16.12.2020
LV16.12.2020
NL16.12.2020
RS16.12.2020
SE16.12.2020
BG16.03.2021
NO16.03.2021
GR17.03.2021
Former [2021/28]FI16.12.2020
HR16.12.2020
LV16.12.2020
RS16.12.2020
SE16.12.2020
BG16.03.2021
NO16.03.2021
GR17.03.2021
Former [2021/23]FI16.12.2020
LV16.12.2020
RS16.12.2020
SE16.12.2020
BG16.03.2021
NO16.03.2021
GR17.03.2021
Former [2021/22]FI16.12.2020
RS16.12.2020
NO16.03.2021
Former [2021/20]FI16.12.2020
Documents cited:Search[Y]EP1002108  (ROUSSY INST GUSTAVE [FR], et al);
 [Y]EP1750707  (SANOFI PASTEUR [FR]);
 [Y]EP2214705  (DOBEEL CO LTD [KR]);
 [Y]WO2011044246  (CLEVELAND BIOLABS INC [US], et al);
 [Y]EP2572715  (3M INNOVATIVE PROPERTIES CO [US]);
 [XP]WO2015168379  (HARVARD COLLEGE [US], et al);
International search[Y]JP2001510806  ;
 [Y]JP2006512391  ;
 [Y]JP2007514725  ;
 [Y]JP2008540625  ;
 [Y]JP2011506309  ;
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.